JPH0466516A - Liquid cosmetic for hair - Google Patents
Liquid cosmetic for hairInfo
- Publication number
- JPH0466516A JPH0466516A JP17476690A JP17476690A JPH0466516A JP H0466516 A JPH0466516 A JP H0466516A JP 17476690 A JP17476690 A JP 17476690A JP 17476690 A JP17476690 A JP 17476690A JP H0466516 A JPH0466516 A JP H0466516A
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- hair
- carbon chain
- odd
- carbon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 14
- 239000007788 liquid Substances 0.000 title claims abstract description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 32
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 30
- 229930195729 fatty acid Natural products 0.000 claims abstract description 30
- 239000000194 fatty acid Substances 0.000 claims abstract description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 23
- 150000005690 diesters Chemical class 0.000 claims abstract description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- -1 fatty acid ester Chemical class 0.000 abstract description 17
- 150000002148 esters Chemical class 0.000 abstract description 5
- 229940088597 hormone Drugs 0.000 abstract description 3
- 239000005556 hormone Substances 0.000 abstract description 3
- 239000003410 keratolytic agent Substances 0.000 abstract description 3
- 229940088594 vitamin Drugs 0.000 abstract description 3
- 239000011782 vitamin Substances 0.000 abstract description 3
- 235000013343 vitamin Nutrition 0.000 abstract description 3
- 229930003231 vitamin Natural products 0.000 abstract description 3
- FXNFFCMITPHEIT-UHFFFAOYSA-N Ethyl 10-undecenoate Chemical compound CCOC(=O)CCCCCCCCC=C FXNFFCMITPHEIT-UHFFFAOYSA-N 0.000 abstract description 2
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 abstract description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 abstract description 2
- 239000003921 oil Substances 0.000 abstract description 2
- 239000004094 surface-active agent Substances 0.000 abstract description 2
- 229910052799 carbon Inorganic materials 0.000 abstract 3
- 239000000645 desinfectant Substances 0.000 abstract 1
- 125000000962 organic group Chemical group 0.000 description 26
- 230000000694 effects Effects 0.000 description 22
- 230000003779 hair growth Effects 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 6
- 201000004384 Alopecia Diseases 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 5
- 229940031016 ethyl linoleate Drugs 0.000 description 5
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical group NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 231100000360 alopecia Toxicity 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 230000003797 telogen phase Effects 0.000 description 4
- 235000015961 tonic Nutrition 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 3
- KWKVAGQCDSHWFK-VNKDHWASSA-N Methyl sorbate Chemical compound COC(=O)\C=C\C=C\C KWKVAGQCDSHWFK-VNKDHWASSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical group C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 239000001375 methyl (2E,4E)-hexa-2,4-dienoate Substances 0.000 description 3
- 150000004671 saturated fatty acids Chemical class 0.000 description 3
- 235000003441 saturated fatty acids Nutrition 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- HPEUJPJOZXNMSJ-UHFFFAOYSA-N Methyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC HPEUJPJOZXNMSJ-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- MMKRHZKQPFCLLS-UHFFFAOYSA-N ethyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OCC MMKRHZKQPFCLLS-UHFFFAOYSA-N 0.000 description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 2
- 229940093471 ethyl oleate Drugs 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N inositol Chemical group OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 229940049918 linoleate Drugs 0.000 description 2
- UQDUPQYQJKYHQI-UHFFFAOYSA-N methyl laurate Chemical compound CCCCCCCCCCCC(=O)OC UQDUPQYQJKYHQI-UHFFFAOYSA-N 0.000 description 2
- IZFGRAGOVZCUFB-HJWRWDBZSA-N methyl palmitoleate Chemical compound CCCCCC\C=C/CCCCCCCC(=O)OC IZFGRAGOVZCUFB-HJWRWDBZSA-N 0.000 description 2
- ZAZKJZBWRNNLDS-UHFFFAOYSA-N methyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC ZAZKJZBWRNNLDS-UHFFFAOYSA-N 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
- 231100000245 skin permeability Toxicity 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical group OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-VAWYXSNFSA-N 9-Octadecenoic acid, ethyl ester Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-VAWYXSNFSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- QYDYPVFESGNLHU-ZHACJKMWSA-N Methyl (9E)-9-octadecenoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OC QYDYPVFESGNLHU-ZHACJKMWSA-N 0.000 description 1
- 206010073150 Multiple endocrine neoplasia Type 1 Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- XKGDWZQXVZSXAO-ADYSOMBNSA-N Ricinoleic Acid methyl ester Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(=O)OC XKGDWZQXVZSXAO-ADYSOMBNSA-N 0.000 description 1
- XKGDWZQXVZSXAO-SFHVURJKSA-N Ricinolsaeure-methylester Natural products CCCCCC[C@H](O)CC=CCCCCCCCC(=O)OC XKGDWZQXVZSXAO-SFHVURJKSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical class CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-M dec-9-enoate Chemical compound [O-]C(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-M 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 235000019961 diglycerides of fatty acid Nutrition 0.000 description 1
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- CAMHHLOGFDZBBG-UHFFFAOYSA-N epoxidized methyl oleate Natural products CCCCCCCCC1OC1CCCCCCCC(=O)OC CAMHHLOGFDZBBG-UHFFFAOYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- WFZQLUSOXHIVKL-QXMHVHEDSA-N ethyl (13Z)-docosenoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCC WFZQLUSOXHIVKL-QXMHVHEDSA-N 0.000 description 1
- SVEDZEIUAKXCCX-FPLPWBNLSA-N ethyl 9Z-tetradecenoate Chemical compound CCCC\C=C/CCCCCCCC(=O)OCC SVEDZEIUAKXCCX-FPLPWBNLSA-N 0.000 description 1
- ZYNDJIBBPLNPOW-UHFFFAOYSA-N eurucic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCCCCCC(=O)OC ZYNDJIBBPLNPOW-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical group O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- CAAULPUQFIIOTL-UHFFFAOYSA-N methyl dihydrogen phosphate Chemical compound COP(O)(O)=O CAAULPUQFIIOTL-UHFFFAOYSA-N 0.000 description 1
- ZYNDJIBBPLNPOW-KHPPLWFESA-N methyl erucate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OC ZYNDJIBBPLNPOW-KHPPLWFESA-N 0.000 description 1
- RWIPSJUSVXDVPB-SREVYHEPSA-N methyl myristoleate Chemical compound CCCC\C=C/CCCCCCCC(=O)OC RWIPSJUSVXDVPB-SREVYHEPSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- QTDSLDJPJJBBLE-PFONDFGASA-N octyl (z)-octadec-9-enoate Chemical compound CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC QTDSLDJPJJBBLE-PFONDFGASA-N 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-M pentadecanoate Chemical compound CCCCCCCCCCCCCCC([O-])=O WQEPLUUGTLDZJY-UHFFFAOYSA-M 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- HBDHXDBPCVDGQN-FPLPWBNLSA-N propan-2-yl (z)-tetradec-9-enoate Chemical compound CCCC\C=C/CCCCCCCC(=O)OC(C)C HBDHXDBPCVDGQN-FPLPWBNLSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- FDUURQHLBXRCMJ-FPLPWBNLSA-N propyl (z)-tetradec-9-enoate Chemical compound CCCC\C=C/CCCCCCCC(=O)OCCC FDUURQHLBXRCMJ-FPLPWBNLSA-N 0.000 description 1
- SFPNSCZLRJDTGT-ACQXMXPUSA-N propyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(=O)OCCC SFPNSCZLRJDTGT-ACQXMXPUSA-N 0.000 description 1
- FTBUKOLPOATXGV-UHFFFAOYSA-N propyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCC FTBUKOLPOATXGV-UHFFFAOYSA-N 0.000 description 1
- BTAXGNQLYFDKEF-UHFFFAOYSA-N propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCC BTAXGNQLYFDKEF-UHFFFAOYSA-N 0.000 description 1
- DPBVJRXPSXTHOL-UHFFFAOYSA-N propyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCC DPBVJRXPSXTHOL-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- XKGDWZQXVZSXAO-UHFFFAOYSA-N ricinoleic acid methyl ester Natural products CCCCCCC(O)CC=CCCCCCCCC(=O)OC XKGDWZQXVZSXAO-UHFFFAOYSA-N 0.000 description 1
- 102220279244 rs1555053901 Human genes 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000003511 tertiary amides Chemical class 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940075466 undecylenate Drugs 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、経皮吸収性の良好な、養毛効果のある頭髪化
粧料に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a hair cosmetic with good transdermal absorption and a hair-nourishing effect.
従来より、各種の薬効剤を配合した養毛剤が知られてい
る。このような薬効剤としては、例えばビタミンEなど
のビタミン類、セリン、メチオニンなどのアミノ酸類、
アセチルコリン誘導体などの血管拡張剤、紫根エキス等
の抗炎症剤、エストラジオールなどの女性ホルモン剤、
セファランチンなどの皮膚機能光進剤、パントテン酸銅
などのメラニン合成触媒剤、サリチル酸などの角質溶解
剤などが使用されている。BACKGROUND ART Hair tonics containing various medicinal agents have been known. Examples of such medicinal agents include vitamins such as vitamin E, amino acids such as serine and methionine,
Vasodilators such as acetylcholine derivatives, anti-inflammatory agents such as purple root extract, female hormones such as estradiol,
Skin function brightening agents such as cephalanthine, melanin synthesis catalysts such as copper pantothenate, and keratolytic agents such as salicylic acid are used.
これに対して、養毛効果を有する新しい薬効成分として
は、奇数鎖長を有する脂肪酸又はその誘導体が見出され
、それらを有効成分とする養毛剤が提案されている(特
公昭63−41363)。On the other hand, fatty acids with odd chain lengths or derivatives thereof have been discovered as new medicinal ingredients having a hair-nourishing effect, and a hair-nourishing agent containing these as active ingredients has been proposed (Japanese Patent Publication No. 63-41363).
しかしながら、ここに開示された養毛剤組成では、有効
成分の経皮吸収性が不十分であるため、十分に養毛効果
が発揮されていないのが現状であり、経皮吸収性を向上
させることにより、より一層すぐれた養毛効果が発揮さ
れることが期待されている。However, with the hair growth agent composition disclosed herein, the percutaneous absorption of the active ingredients is insufficient, so the hair growth effect is not fully demonstrated. , it is expected that even more excellent hair-nourishing effects will be exhibited.
本発明は、養毛効果を有する奇数鎖脂肪酸又はその誘導
体の経皮吸収を向上させた頭髪化粧料を提供することを
目的とする。An object of the present invention is to provide a hair cosmetic that improves transdermal absorption of odd-number chain fatty acids or derivatives thereof that have a hair-nourishing effect.
本発明は、奇数鎖脂肪酸又はその誘導体をアルコール性
媒体と溶解させるとともに、特定の脂肪酸エステルを併
用する頭皮からの吸収性が向上し、優れた養毛効果が発
揮されるとの知見に基づいてなされたものである。The present invention is based on the knowledge that when an odd-chain fatty acid or its derivative is dissolved in an alcoholic medium and a specific fatty acid ester is used in combination, the absorption from the scalp is improved and an excellent hair growth effect is exhibited. It has been done.
すなわち、本発明は、(A)炭素原子数3〜25の奇数
の炭素鎖長を有する脂肪酸又はその誘導体と、(B)偶
数の炭素鎖長を有する脂肪酸のモノ又はジエステルを含
有し、かつ低級アルコール含tが40重量%以上である
ことを特徴とする液体頭髪化粧料を提供する。That is, the present invention contains (A) a fatty acid or a derivative thereof having an odd carbon chain length of 3 to 25 carbon atoms, and (B) a mono- or diester of a fatty acid having an even carbon chain length, and a lower To provide a liquid hair cosmetic characterized by having an alcohol content of 40% by weight or more.
この発明の中成分(A)として用いる奇数の脂肪酸は、
炭素鎖を構成している炭素原子の数が奇数のものであっ
て、飽和脂肪酸及び不飽和脂肪酸が含まれる。不飽和脂
肪酸は複数の二重結合を含んでいてもよい。また、プロ
ピオン酸(炭素鎖長3)や吉草酸(炭素鎖長5)のよう
な低級脂肪酸でも、ペンタデカン酸(炭素鎖長15)や
ヘプタデカン酸(炭素鎖長17)のような高級脂肪酸で
もよい。このうち炭素数11〜17のものが好ましい。The odd-numbered fatty acids used as the component (A) of this invention are:
Fatty acids with an odd number of carbon atoms constituting a carbon chain include saturated fatty acids and unsaturated fatty acids. Unsaturated fatty acids may contain multiple double bonds. It may also be lower fatty acids such as propionic acid (carbon chain length 3) and valeric acid (carbon chain length 5), or higher fatty acids such as pentadecanoic acid (carbon chain length 15) or heptadecanoic acid (carbon chain length 17). . Among these, those having 11 to 17 carbon atoms are preferred.
この発明では、このような奇数鎖長の脂肪酸のいずれの
誘導体をも用いることができる。ただし、人体に悪影響
を及ぼすものを用いることができないことは言うまでも
ない。好ましい誘導体の例として次のものがあげられる
。In this invention, any derivative of such odd chain length fatty acids can be used. However, it goes without saying that it is not possible to use substances that have an adverse effect on the human body. Examples of preferred derivatives include the following.
(イ)下記一般弐N〕又は〔■〕で示されるモグリセラ
イド。(a) Moglycerides indicated by General 2N] or [■] below.
(1) (n)
CH2OCORCH2(011)
C1l (OH) C)IOCORC
H2(01() CH2(OH)ここ
で、Rは偶数の炭素鎖長を有する直鎖式有機基を表わす
。(1) (n) CH2OCORCH2(011) C1l (OH) C) IOCORC
H2(01() CH2(OH) where R represents a linear organic group with an even carbon chain length.
(ロ)下記一般式(II[)又は(IV)で示されるジ
グリセライド。(b) A diglyceride represented by the following general formula (II[) or (IV).
(III) (IV)C)lzO
cOR+ C)IzOCOR+C)l
OcOR2C)l (OH)
CH2(OH) CH20CORZこ
こで、R,及びR2は少なくともいずれか一方は偶数の
炭素鎖長を有する直鎖式有機基を表わす。R3又はR2
のいずれか一方が偶数の炭素鎖長を有する鎖式有機基で
あればこの発明の効果は得られ、他の一方は奇数の炭素
鎖長を有する鎖式有機基であってもよい。しかしながら
、奇数鎖長の脂肪酸のジグリセライドであることが特に
好ましい。(III) (IV)C) lzO
cOR+ C)IzOCOR+C)l
OcOR2C)l (OH) CH2(OH) CH20CORZ where at least one of R and R2 represents a linear organic group having an even carbon chain length. R3 or R2
The effects of the present invention can be obtained if either one of them is a chain organic group having an even number of carbon chain lengths, and the other one may be a chain organic group having an odd number of carbon chain lengths. However, diglycerides of fatty acids of odd chain length are particularly preferred.
(ハ)下記一般式(■〕で示されるトリグリセライド。(c) Triglyceride represented by the following general formula (■).
(V) CH20COR。(V) CH20COR.
Cll0COR2
CH2OCOR3
ここで、R,、R2及びR3のうち少なくとも1つは偶
数の炭素鎖長を有する直鎖式有機基を表わず。R+、R
z及びR3のうち少なくともいずれか1つが偶数の炭素
鎖長を有する鎖式有機基であればこの発明の効果は得ら
れ、他のものは奇数の炭素鎖長を有する鎖式有機基であ
ってもかまわない。しかしながら、奇数鎖拍の脂肪酸の
トリグリセライドが特に好ましい。Cll0COR2 CH2OCOR3 where at least one of R,, R2 and R3 does not represent a linear organic group having an even carbon chain length. R+, R
The effects of the present invention can be obtained if at least one of z and R3 is a chain organic group having an even carbon chain length, and the other is a chain organic group having an odd carbon chain length. I don't mind. However, triglycerides of odd-numbered fatty acids are particularly preferred.
(ニ)下記一般式C■)で示される脂肪酸塩。(d) Fatty acid salt represented by the following general formula C■).
〔■]
(RCOO)、、門
ここで、Rは偶数の炭素鎖長を有する直鎖式有機基、M
は金属原子、nはMの価数に対応した整数を表わす。代
表的なものはRCOONa、 RCOOK 、及びRC
OOLiなとである。[■] (RCOO), where R is a linear organic group with an even carbon chain length, M
represents a metal atom, and n represents an integer corresponding to the valence of M. Representative ones are RCOONa, RCOOK, and RC
It is OOLi nato.
(ホ)下記一般式〔■〕で示されるエステル〔■〕
RCOOR’
ここで、Rは偶数の炭素鎖長を有する直鎖式有機基、R
′は炭素原子数が偶数の1価若しくは2価の脂肪族アル
コール残基、ポリオキシエチレン残基、ソルビタン残基
、又はショ糖残基を表わす。(e) Ester represented by the following general formula [■] [■] RCOOR' Here, R is a linear organic group having an even carbon chain length, R
' represents a monovalent or divalent aliphatic alcohol residue having an even number of carbon atoms, a polyoxyethylene residue, a sorbitan residue, or a sucrose residue.
1価アルコールの典型例はメタノール及びエタノールで
あり、アミノ残基の典型例はモノ、ジ、トリエタノール
アミンである。Typical examples of monohydric alcohols are methanol and ethanol, and typical examples of amino residues are mono-, di-, and triethanolamine.
(へ)下記一般式〔■〕で表わされる第17ミド〔■〕
RCONR’ R”
ここで、Rは偶数の炭素鎖長を有する直鎖式有機基を表
わす。R′及びR“は水素又は人体に悪影響を与えるこ
とがない有機基を表わす。(f) The 17th compound represented by the following general formula [■] [■] RCONR'R'' Here, R represents a linear organic group having an even number of carbon chain lengths. R' and R'' are hydrogen or Represents an organic group that does not have any adverse effects on the human body.
(ト)下記一般式[IX)で表わされる第2アミド(I
X)
RICONCOR2
R′
ここで、R3及びR2のうち少なくともどちらか一方は
偶数の炭素鎖長を有する直鎖式有機基を表わす。R6及
びR2のうち少なくとも一方が偶数鎖長の有機基であれ
ばこの発明の効果を得ることができ、他のもの及びR′
は人体に悪影響を与えないものであればどのような有機
基であってもよい。もっとも、双方とも偶数鎖長の直鎖
式有機基であることが特に好ましい。R′は水素であっ
てもよい。(g) The second amide (I) represented by the following general formula [IX]
X) RICONCOR2 R' Here, at least one of R3 and R2 represents a linear organic group having an even number of carbon chain lengths. If at least one of R6 and R2 is an organic group with an even chain length, the effects of the present invention can be obtained;
may be any organic group as long as it does not have an adverse effect on the human body. However, it is particularly preferred that both groups are linear organic groups with even chain lengths. R' may be hydrogen.
(チ)下記一般式(X)で表わされる第3アミド。(H) A tertiary amide represented by the following general formula (X).
(X)
RrC0NC0Rz
OR3
ここで、R,、R,及びR3のうち少なくとも1つは偶
数の炭素鎖長を有する直鎖式有機基を表わす。Rr、R
z及びR3のうち少なくとも1つが偶数鎖長の有機基で
あればこの発明の効果を得ることができ、他のものは人
体に悪影響を与えないものであればどのような有機基で
あってもよい。(X) RrC0NC0Rz OR3 Here, at least one of R, , R, and R3 represents a linear organic group having an even carbon chain length. Rr, R
The effects of the present invention can be obtained if at least one of z and R3 is an organic group with an even chain length, and the other organic groups can be any organic group as long as they do not have an adverse effect on the human body. good.
もっとも、これら3つともが偶数鎖長の直鎖式有機基で
あることが特に好ましい。However, it is particularly preferable that all three of these groups are straight-chain organic groups with even chain lengths.
(ワ)下記一般式(XI)で表わされる二塩基酸及びそ
の塩
[XI]
HOOCRCOOH
ここで、Rは奇数の炭素鎖長を有する直鎖式有機基を表
わす。(W) Dibasic acid and its salt represented by the following general formula (XI) [XI] HOOCRCOOH Here, R represents a linear organic group having an odd carbon chain length.
(ヌ)下記一般式[Xn)で表わされるステロールエス
テル
[XII)
ここで、Rは偶数の炭素鎖長を有する直鎖式有機基を表
わす。(J) Sterol ester represented by the following general formula [Xn] [XII] Here, R represents a linear organic group having an even number of carbon chain lengths.
(ル)下記一般式(XI[[)で表わされるリン脂質(
XI[[)
C)lzOcOR+
CHOCOR2
ここで、R1及びR2は鎖式有機基であって、これらの
うち少なくともいずれか一方、特に好ましくは双方とも
偶数の炭素鎖長を有する直鎖式有機基を表わす。Xはコ
リン残基、エタノールアミン残基、セリン残基、又はイ
ノシトール残基を表わす。Xがコリン残基のときはフォ
スファチジルコリン、エタノールアミン残基のときはフ
ォスファチジルエタノールアミン、セリン残基のときは
フォスファチジルセリン、イノシトールのときはフォス
ファチジルイノシトールとなる。(L) Phospholipids represented by the following general formula (XI[[)
Xl . X represents a choline residue, an ethanolamine residue, a serine residue, or an inositol residue. When X is a choline residue, it becomes phosphatidylcholine, when it is an ethanolamine residue, it becomes phosphatidylethanolamine, when it is a serine residue, it becomes phosphatidylserine, and when it is inositol, it becomes phosphatidylinositol.
(オ)下記一般式(XTV)で表わされるフォスファチ
ジン酸
[×■〕
CH20COR
CH2COR2
ここで、R1及びR2は鎖式有機基てあって、これらの
うち少なくともどちらが一力、特に好ましくは双方とも
偶数の炭素鎖長を有する直鎖式有機基を表わす。(E) Phosphatidic acid represented by the following general formula (XTV) [×■] CH20COR CH2COR2 Here, R1 and R2 are chain organic groups, and at least one of them is a chain organic group, and particularly preferably both are Represents a straight-chain organic group with an even number of carbon chain lengths.
(ワ)下記−C式(XV)で表わされるスフィンゴ脂質
CXV)
C)13(CII2)+zcH=cI(−C)l−CI
−(Jlz−0−XOll NH
C−・O
ここで、Rは偶数の炭素鎖長を有する直鎖式有機基、X
ば糖残基、リン酸残基、又はコリン若しくはエタノール
アミンのようなアミン塩基残基を表わす。(W) Sphingolipid CXV represented by the following -C formula (XV)) C) 13(CII2)+zcH=cI(-C)l-CI
-(Jlz-0-XOll NH C-・O where R is a linear organic group with an even carbon chain length,
represents a sugar residue, a phosphate residue, or an amine base residue such as choline or ethanolamine.
上記成分(A)の頭髪化粧料中の含有量は任意とするこ
とができるが、0.1〜10重量%(以下%と略称する
)とするのが好ましく、より好ましくは0.5〜5%で
ある。The content of the above component (A) in the hair cosmetic can be set arbitrarily, but it is preferably 0.1 to 10% by weight (hereinafter abbreviated as %), more preferably 0.5 to 5% by weight. %.
本発明で成分(B)とし7て用いる偶数の炭素鎖長を有
する脂肪酸のモノ又はジエステルは、成分(A)の経皮
吸収促進剤として作用し、炭素数2〜30、好ましくは
8〜22の偶数の脂肪酸と炭素数1〜20、好ましくは
1〜12の1価のアルコール又は多価アルコールとのモ
ノ又はジエステルがあげられる。このうち、上記脂肪酸
と1価アルコールとのエステルが好ましい。尚、成分(
B)の脂肪酸には飽和脂肪酸、不飽和脂肪酸のいずれを
も使用することができる。飽和脂肪酸のエステルとして
は、ラウリン酸メチル、ラウリン酸エチル、ラウリン酸
プロピル、ミリスチン酸メチル、ミリスチン酸エチル、
ミリスチン酸プロピル、バルミチン酸メチル、バルミチ
ン酸エチル、バルミチン酸プロピル、ステアリン酸メチ
ル、ステアリン酸ユ千ル、ステアリン酸プロピル等の−
・種又は種板)x Iy′)/¥jS合物が例示される
。又、不飽和脂肪酸のエステルとしては、オブシッル酸
メチル、ウンデシレン酸エチル、リンデル酸プロピル、
ミリスl−1,(ン酸メチル、ミリストレイン酸エチル
、ミリストレイン酸プロピル、ミリストレイン酸イソプ
ロピル、パルミトレイン酸メチル、パルミトレイン酸メ
チル、バルミIレイン酸プロピル、パルミトレイン酸イ
ソプロピル、ペトロセリン酸エチル、ペトロセリン酸プ
ロピル、オレイン酸エチル、オレイン酸オクチル、オレ
イン酸デシル、エライジン酸メ(ル、エライジン酸エチ
ル、エライジン酸プロピル、リシノール酸メチル、リノ
ー酸エチル、リシノール酸プロピル、ガトレイン酸メチ
ル、ガトレイン酸エチル、ガドレイン酸プロピル、エル
カ酸メチル、エルカ酸エチル、エルカ酸〕”Dビル、ソ
ルヒン酸メチJし、ソルビン酸エチル、υノール酸メ1
ル、リノール酸エチル、υノール酸ブ11ビル、ヒラゴ
酸メチル、ヒラゴ酸ユチル、リルン酸メチル、リノール
酸エチル、リルン酸プロピル、T−リルン酸メチル、T
リノール酸エチル、T−リルン酸プロピル等を挙げるこ
とができ、これら1種又は2種以−トの混合物を用いる
ことができる。尚、脂肪酸エステルとして、不飽和脂肪
酸ニスデルがより好ましい。The fatty acid mono- or diester having an even carbon chain length used as component (B) in the present invention acts as a transdermal absorption enhancer for component (A), and has 2 to 30 carbon atoms, preferably 8 to 22 carbon atoms. Examples include mono- or diesters of even-numbered fatty acids and monohydric alcohols or polyhydric alcohols having 1 to 20 carbon atoms, preferably 1 to 12 carbon atoms. Among these, esters of the above fatty acids and monohydric alcohols are preferred. In addition, the ingredients (
As the fatty acid B), both saturated fatty acids and unsaturated fatty acids can be used. Esters of saturated fatty acids include methyl laurate, ethyl laurate, propyl laurate, methyl myristate, ethyl myristate,
Propyl myristate, methyl balmitate, ethyl valmitate, propyl valmitate, methyl stearate, yucyl stearate, propyl stearate, etc.
- Seed or seed plate) x Iy')/\jS compound is exemplified. In addition, as esters of unsaturated fatty acids, methyl obsylate, ethyl undecylenate, propyl linderate,
Myris l-1, (methyl phosphate, ethyl myristoleate, propyl myristoleate, isopropyl myristoleate, methyl palmitoleate, methyl palmitoleate, propyl balmyleate, isopropyl palmitoleate, ethyl petroselate, propyl petroselate) , ethyl oleate, octyl oleate, decyl oleate, methyl elaidate, ethyl elaidate, propyl elaidate, methyl ricinoleate, ethyl linoleate, propyl ricinoleate, methyl gatoleate, ethyl gatoleate, propyl gadolate , methyl erucate, ethyl erucate, erucic acid] D, methyl sorbate, methyl sorbate, methyl sorbate,
ru, ethyl linoleate, υbutyl linoleate, methyl hyalate, utilyl hyalate, methyl lylunate, ethyl linoleate, propyl lylunate, T-methyl lylunate, T
Examples include ethyl linoleate and propyl T-linoleate, and one or a mixture of two or more of these can be used. In addition, as the fatty acid ester, unsaturated fatty acid Nisdel is more preferable.
成分(B)の含有量は任意とすることができるが、頭髪
化粧料中に0.1〜50%、好ましくは0.5〜20%
含有さセるのがよい。又、成分(A)と成分(B)の重
量比も任意とすることができるが、A/B=100/1
〜11500、好ましくは10/1〜1/40とするの
がよい。The content of component (B) can be arbitrary, but it is 0.1 to 50%, preferably 0.5 to 20% in the hair cosmetic.
It is better to contain it. Furthermore, the weight ratio of component (A) and component (B) can be arbitrary, but A/B=100/1.
~11500, preferably 10/1~1/40.
本発明では、さらに低級アルコールを40%以上、好ま
しくは40〜99.5%、より好ましくは75〜99%
含有さセる。ここで、低級アルコールとしては、炭素数
1〜Gのアルニ7−ル、例えばメタノール、エタノール
、プロパツール、イソプロパツール、ブタノール、イソ
ブタノール、ペンタノール、エチレングリニ1−)し、
フ゛ロビレングリコール、グリセリン等を挙げるごとが
出来、これらの1種又は2種以上を用いることが出来る
。これらのうち、特にエタノールが好ましい。In the present invention, the lower alcohol is further contained in an amount of 40% or more, preferably 40 to 99.5%, more preferably 75 to 99%.
Contains. Here, the lower alcohol includes alniol having 1 to G carbon atoms, such as methanol, ethanol, propatool, isopropanol, butanol, isobutanol, pentanol, ethylene glycol,
Examples include filobylene glycol and glycerin, and one or more of these can be used. Among these, ethanol is particularly preferred.
本発明では、上記低級アルコールを使用することにより
、均一な溶液状態とすることができ、この点で乳化型の
ものとは異なるのである。従って、本発明の頭髪化粧料
には、系が乳化型にならない限度で水を共存させること
ができる。In the present invention, by using the above-mentioned lower alcohol, a uniform solution state can be obtained, and in this point, it is different from an emulsion type. Therefore, the hair cosmetic composition of the present invention can contain water as long as the system does not become emulsified.
本発明の頭髪化粧料は、更に補助成分として、慣用の種
々のもの、例えば界面活性剤、油分等を配合することが
出来る。また薬効成分としてビタミン類、ホルモン類、
アミノ酸類、血管拡張剤、抗炎症剤、細胞賦活剤などの
既知の養毛剤や、角質溶解剤、殺菌剤、既知の経皮吸収
促進剤などをも同時に配合し得る。The hair cosmetic of the present invention may further contain various commonly used auxiliary ingredients, such as surfactants and oils. In addition, the medicinal ingredients include vitamins, hormones,
Known hair nourishing agents such as amino acids, vasodilators, anti-inflammatory agents, and cell activators, keratolytic agents, bactericidal agents, known transdermal absorption enhancers, and the like may also be added at the same time.
本発明の頭髪化粧料によれば有効成分の経皮吸収性が向
上するので、より優れた養毛効果を発揮することが出来
る。また、経皮吸収性が改善されるため、有効成分の配
合濃度を下げることにより、同程度の養毛効果を得るこ
とができる。According to the hair cosmetic of the present invention, the transdermal absorption of the active ingredient is improved, so that it is possible to exhibit a more excellent hair-nourishing effect. Furthermore, since transdermal absorption is improved, the same level of hair growth effect can be obtained by lowering the concentration of the active ingredient.
次に実施例により本発明を説明する。Next, the present invention will be explained with reference to examples.
実施例1
表−1に示す液体組成物の経皮吸収を次のようにして測
定した。Example 1 The transdermal absorption of the liquid composition shown in Table 1 was measured as follows.
モルモッ) (Hartley系、雄)の背部皮膚を切
り取り、これを垂直型拡散セルのドナーとレセプターの
間に表皮側が上になるようにはさみ固定した。The dorsal skin of a guinea pig (Hartley strain, male) was cut out and fixed between the donor and receptor of a vertical diffusion cell with the epidermis facing upward.
次に、レセプター側を生理的食塩水で満した後、撹拌し
なから32°Cに保温し、続いてドナー側の皮膚上に、
被験試料が50μ!添加した。その24時間後に生理的
食塩水をサンプリングし、透過した奇数炭素鎖長を有す
る脂肪酸またはその誘導体の量を測定した。The receptor side was then filled with physiological saline, kept warm at 32°C without stirring, and then applied onto the donor side skin.
The test sample is 50μ! Added. 24 hours later, the physiological saline was sampled, and the amount of permeated fatty acid or derivative thereof having an odd carbon chain length was measured.
なお、結果は、脂肪酸エステルを入れない成分の透過率
を1として、それぞれの組成の透過率を、相対値で表わ
した。Note that the results are expressed as relative values of the transmittance of each composition, with the transmittance of the component containing no fatty acid ester being 1.
表−1より、脂肪酸エステル及び低級アルコールを加え
ると成分(A、)の皮膚透過率が向上し、不飽和脂肪酸
エステルを使用した場合、皮膚透過率がより向上するこ
とがわかる。Table 1 shows that the skin permeability of component (A,) is improved when a fatty acid ester and a lower alcohol are added, and the skin permeability is further improved when an unsaturated fatty acid ester is used.
次に養毛効果を次の方法により調べた。Next, the hair growth effect was investigated using the following method.
体重約2.5 kgの雄二ユージーラントポワイト種ウ
サギ12〜15羽を一群とし、背部を除毛し、休止期に
あるもののみを実験に供U7た。休止期Qこあるものの
除毛した背部に被験試料を各0.2 dづつ、週1回、
30〜60日間塗布し、休止期毛が成長期しに変換する
のに要する口数を調べた。なお、養毛効果の指標として
用いた「促進日数」とは、無塗布部に比べて、休止期毛
から成長期毛への変換が何日間促進されたかを示すもの
である。A group of 12 to 15 male Eugie Landpoite rabbits weighing approximately 2.5 kg was prepared, the hair on the back was removed, and only those in the telogen phase were used for the experiment (U7). Apply the test sample for 0.2 d each to the hair-removed back of a telogen Q animal once a week.
The product was applied for 30 to 60 days, and the number of coats required for the telogen hair to convert into the anagen hair was determined. The "number of days of promotion" used as an index of the hair growth effect indicates how many days the conversion from telogen hair to anagen hair was promoted compared to the unapplied area.
養毛効果を、下記の表−2に示す基準Qこ基づき評価し
た。The hair nourishing effect was evaluated based on the standard Q shown in Table 2 below.
結果をまとめて表 表 3及び表 4に示す。Table of results table 3 and table 4.
表−3及び表−4より、脂肪酸ニスチル及び低級アルコ
ールを加えることにより、ウサギの養毛効果がさらに向
上することがわかる。From Tables 3 and 4, it can be seen that the hair growth effect of rabbits is further improved by adding the fatty acid nistyl and lower alcohol.
実施例2
次に、本発明の頭髪化粧料の処方例を示す。いずれの例
においても優れた養毛効果を示すことが6育認された。Example 2 Next, a formulation example of the hair cosmetic of the present invention will be shown. In all of the examples, it was confirmed that the plants exhibited excellent hair growth effects.
処方例1 (養毛剤)
配合成分 重量(%)ペンタデカン酸
グリセリF’ 4.0Aレイン酸エチル
4.0α−トコフェロール 0
.5サフラワー油 0.3パルミチ
ン酸イソプロピル 3. OP叶(20モル)グ
リセリルモ 3.0ノイソステアl/−ト
!−メン1−−ル 0.1香料
0.3
99.5%エタノール 残部処方例2(
養毛剤)
配合成分
n−)リヘンデカノイン
リノール酸エチル
ヒマシ油
オリーブ油
グリセリルモノステアレート
ミリスチン酸イソプロピル
ニコチン酸ベンジル
香料
イソプロパツール
処方例3(養毛剤)
配合成分
n−)リゾカン酸エチル
ミリストレイン酸メチル
セファランチン
POE(15)グリセリルモノ
ステアレート
サフラワー油
!−メントール
香料
重量(%)
5.0
10、0
1.0
1.0
0.5
3.0
0、003
0.3
残部
重量(%)
5.0
3.0
1.0
0、5
0.3
0.1
0.3
プロピレングリコール 残部処方例4(ヘア
トニック)
配合成分 重量(%)n−)リヘンデ
カノイン 2.0エライジン酸プロピル
5.0イソプロピルメチルフエノール 0.
05ヒノキチオール 0.1ヒマシ油
10.0香料 0
.5
エタノール 残部実施例3
実施例2の処方例1を脱毛症患者に施したところ、幅広
い脱毛症に対して有効であり、特に若年性脱毛症、壮年
性脱毛症などの男性型脱毛症、及び円形脱毛症に優れた
育毛効果を示すことが明らかとなった。Formulation example 1 (hair tonic) Ingredients Weight (%) Glycery pentadecanoate F' 4.0A Ethyl oleate
4.0α-tocopherol 0
.. 5 Safflower oil 0.3 Isopropyl palmitate 3. OP Kano (20 mol) Glycerylmo 3.0 Neusostear l/-t! -Men 1--L 0.1 Fragrance
0.3 99.5% ethanol Remaining formulation example 2 (
Hair tonic) Ingredients n-) Lihendecanoin Ethyl linoleate Castor oil Olive oil Glyceryl monostearate Isopropyl myristate Benzyl nicotinate Fragrance Isopropatool Prescription Example 3 (Hair tonic) Ingredients n-) Ethyl lysocanoate Methyl myristoleate Cephalanthine POE (15) Glyceryl monostearate safflower oil! - Menthol fragrance weight (%) 5.0 10,0 1.0 1.0 0.5 3.0 0,003 0.3 Remaining weight (%) 5.0 3.0 1.0 0,5 0. 3 0.1 0.3 Propylene glycol Remainder Formulation Example 4 (Hair Tonic) Ingredients Weight (%) n-) Lihendecanoin 2.0 Propyl Elaidate
5.0 Isopropylmethylphenol 0.
05 Hinokitiol 0.1 Castor oil 10.0 Fragrance 0
.. 5 Ethanol Remainder Example 3 When Prescription Example 1 of Example 2 was applied to alopecia patients, it was found to be effective against a wide range of alopecias, and was particularly effective against androgenetic alopecia such as juvenile alopecia and middle age alopecia; It has been revealed that it has an excellent hair growth effect on alopecia areata.
また、この養毛剤を使用することによる副作用は全く認
められなかった。上述した実施例の養毛剤を健常人25
名に対してクローズドパンチテストによる皮膚刺激性試
験を行なったところ、結果はいずれも陰性であった(陽
性率0%)。Furthermore, no side effects were observed when using this hair growth agent. The hair growth agent of the above-mentioned example was administered to 25 healthy people.
When a skin irritation test using a closed punch test was conducted on the skin, all results were negative (positive rate 0%).
この様に、本発明にかかる有効成分はいずれも安全性の
高いものである。As described above, all of the active ingredients according to the present invention are highly safe.
手続補正書
3.5.13
平成 年 月
1、事件の表示
平成2年特許願第1
66号
2、発明の名称
液体頭髪化粧料
3、補正をする者
事件との関係
名
称
出
願
(676)う
人
イ
オ
ン
株
式
5、補正命令の日付
自 発
6、補正の対象
明細書の発明の詳細な説明の欄
(1) 明細書第3頁第12行[1の“併用する頭皮
”をr−併用すると頭皮−:に訂正する。Written amendment 3.5.13 May 1, 1998, Indication of the case 1990 Patent Application No. 1 66 2, Title of the invention Liquid hair cosmetics 3, Name related to the person making the amendment Application (676) U Human ion stock 5, date of amendment order 6, column for detailed explanation of the invention in the specification subject to amendment (1) page 3, line 12 of the specification [1. Scalp -: Correct.
(2)同書第4百第15〜16h目の“千グリセライド
。”苓゛モノクIノセライド。コにJT正する。(2) "Thousand Glycerides" in the 400th, 15th to 16th h of the same book. JT corrects Ko.
(3)同書第11頁一般式・XV:、の” CH3(C
H,)、、C11=[:旧[:)l m11−[H,[
] XOHN)l
C・fl
を
r C113(CL)、、C11=C1i−C)+−C
I+−[11,−0−Xtn+ NH
C=口
II J
に訓−正する。(3) General formula, page 11 of the same book, XV: "CH3(C
H,),,C11=[:old[:)l m11-[H,[
]
I+-[11,-0-Xtn+NH C=mouth II J to be corrected.
(4)同書第13頁第4〜5行目の“ウンデシレン酸エ
チルパを「カプロレイン酸エチル、・にg7正する。。(4) In the same book, page 13, lines 4-5, ``Ethyl undecylenate'' is changed to ``Ethyl caproleate, .g7.
(J))同占第1〔;真書1111目の“′被験試料が
゛′4被験試料苓−,・に3F正する1゜
(6) 同書第11頁表−1の成分(B)の゛″ウン
デンレン酸エチル(2,0%)′を「カプロレイン酸エ
チル(20%)jに訂正する。(J)) Dosen No. 1 [; True book 1111 "' test sample is 3F corrected to ゛'4 test sample 蓓-,・1゜ (6) Components (B) of Table 1 on page 11 of the same book Correct "ethyl undenoleate (2.0%)' to "ethyl caproleate (20%)j.
Claims (1)
肪酸又はその誘導体と、 (B)偶数の炭素鎖長を有する脂肪酸のモノ又はジエス
テルを含有し、かつ低級アルコール含量が40重量%以
上であることを特徴とする液体頭髪化粧料。[Scope of Claims] (A) a fatty acid or a derivative thereof having an odd carbon chain length of 3 to 25 carbon atoms, and (B) a mono- or diester of a fatty acid having an even carbon chain length, and containing a lower A liquid hair cosmetic having an alcohol content of 40% by weight or more.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17476690A JP2894805B2 (en) | 1990-07-02 | 1990-07-02 | Liquid hair cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17476690A JP2894805B2 (en) | 1990-07-02 | 1990-07-02 | Liquid hair cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0466516A true JPH0466516A (en) | 1992-03-02 |
JP2894805B2 JP2894805B2 (en) | 1999-05-24 |
Family
ID=15984303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP17476690A Expired - Fee Related JP2894805B2 (en) | 1990-07-02 | 1990-07-02 | Liquid hair cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2894805B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2803749A1 (en) * | 2000-01-18 | 2001-07-20 | Pharmascience Lab | Inhibition of 5 alpha-reductase activity by fatty esters, useful for prostate hypertrophia and adenoma, acne, hyperseborrhea, alopecia, hirsutism and the like |
JP2005206570A (en) * | 2003-12-25 | 2005-08-04 | Lion Corp | Skin conditioning composition and method for promoting transdermal absorption of hair growth tonic |
WO2006114140A1 (en) * | 2005-04-27 | 2006-11-02 | Beiersdorf Ag | Pristanic acid-containing cosmetic preparations |
JP2007178199A (en) * | 2005-12-27 | 2007-07-12 | Nippon Seiki Co Ltd | Vehicle instrument |
JP2012508214A (en) * | 2008-11-10 | 2012-04-05 | ギウリアニ ソシエタ ペル アチオニ | Use of compounds to inhibit 5α-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing the same |
JP2012085684A (en) * | 2010-10-15 | 2012-05-10 | Lion Corp | Application container filled with cosmetic |
JP6296259B1 (en) * | 2016-12-27 | 2018-03-20 | 霧島ホールディングス株式会社 | Hair restorer |
-
1990
- 1990-07-02 JP JP17476690A patent/JP2894805B2/en not_active Expired - Fee Related
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2803749A1 (en) * | 2000-01-18 | 2001-07-20 | Pharmascience Lab | Inhibition of 5 alpha-reductase activity by fatty esters, useful for prostate hypertrophia and adenoma, acne, hyperseborrhea, alopecia, hirsutism and the like |
WO2001052837A3 (en) * | 2000-01-18 | 2002-06-20 | Pharmascience Lab | Use of at least a fatty ester for preparing a composition designed to inhibit 5-$g(a)-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive |
US8318186B2 (en) | 2000-01-18 | 2012-11-27 | Laboratoires Expanscience | Use of at least a fatty ester for preparing a composition designed to inhibit 5-α-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive |
JP2005206570A (en) * | 2003-12-25 | 2005-08-04 | Lion Corp | Skin conditioning composition and method for promoting transdermal absorption of hair growth tonic |
JP4626743B2 (en) * | 2003-12-25 | 2011-02-09 | ライオン株式会社 | Skin conditioning composition and method for promoting percutaneous absorption of hair restorer |
WO2006114140A1 (en) * | 2005-04-27 | 2006-11-02 | Beiersdorf Ag | Pristanic acid-containing cosmetic preparations |
JP2007178199A (en) * | 2005-12-27 | 2007-07-12 | Nippon Seiki Co Ltd | Vehicle instrument |
JP2012508214A (en) * | 2008-11-10 | 2012-04-05 | ギウリアニ ソシエタ ペル アチオニ | Use of compounds to inhibit 5α-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing the same |
JP2012085684A (en) * | 2010-10-15 | 2012-05-10 | Lion Corp | Application container filled with cosmetic |
JP6296259B1 (en) * | 2016-12-27 | 2018-03-20 | 霧島ホールディングス株式会社 | Hair restorer |
JP2018104350A (en) * | 2016-12-27 | 2018-07-05 | 霧島ホールディングス株式会社 | Hair restorer |
WO2018123960A1 (en) * | 2016-12-27 | 2018-07-05 | 霧島ホールディングス株式会社 | Hair growth stimulant |
Also Published As
Publication number | Publication date |
---|---|
JP2894805B2 (en) | 1999-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5927809A (en) | Hair tonic | |
US20100311836A1 (en) | Oil-in-water emulsified cosmetic composition | |
JPH10130128A (en) | Cosmetic material | |
US7846969B2 (en) | Ceramide emulsions | |
JPS6115815A (en) | Cosmetic for hair | |
JPH0466516A (en) | Liquid cosmetic for hair | |
JPS6115809A (en) | Cell activator | |
JP4220838B2 (en) | Topical skin preparation | |
JP4119646B2 (en) | Method for producing ceramide emulsion | |
JP3967292B2 (en) | Water-in-oil emulsion composition | |
JPS62135409A (en) | Hair tonic cosmetic | |
JP4220698B2 (en) | Topical skin preparation | |
JPH0235721B2 (en) | ||
JP2005002020A (en) | Oil-in-water type emulsion cosmetic | |
JP4188150B2 (en) | Skin preparation | |
JP2741143B2 (en) | External preparation for skin | |
JP3258801B2 (en) | Skin metabolism promoter | |
JPH01132511A (en) | Hair tonic cosmetic | |
JP2994484B2 (en) | Hair cosmetics | |
JP2522482B2 (en) | Hair restorer | |
JP2001158719A (en) | Hair grower composition | |
JP4001467B2 (en) | Cosmetic for hair growth | |
JPS63310813A (en) | Composition for hair | |
JP2787696B2 (en) | Hair growth promoter | |
JPH04356408A (en) | Composition for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080305 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090305 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090305 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100305 Year of fee payment: 11 |
|
LAPS | Cancellation because of no payment of annual fees |